Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
multiple sclerosis
CRO
Sanofi will deploy new AI tool in late-stage MS trials
Sanofi, Formation Bio and OpenAI have jointly designed an AI-powered tool that will be rolled out in the former's phase 3 multiple sclerosis trials.
Gabrielle Masson
Nov 13, 2024 7:40am
Sanofi flunks MS study, dealing another blow to Denali pact
Oct 11, 2024 5:56am
Sanofi lifts lid on data behind tolebrutinib’s mixed MS studies
Sep 20, 2024 7:07am
Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials
Sep 2, 2024 1:00am
Siemens Healthineers nets CE Mark for MS relapse risk blood test
Jun 17, 2024 11:30am
Contineum lowers expectations for $110M IPO
Apr 5, 2024 7:00am